Xilio Therapeutics, Inc. (XLO)

NCM – Real Time Price. Currency in USD

8.98

-0.21 (-2.34%)

Market open: Aug 12, 2026, 1:59 PM EDT

9.18

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

12.08.2026

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2 Advancing IND-enabling studies for potential first-in-class multi-specific, masked T cell engager programs targeting CLDN18.2 and PSMA+STEAP1; IND applications anticipated in the second half of 2027 Cash runway into the first quarter of 2028 expected to support key milestones across pipeline of next generation multi-specific I-O therapies WALTHAM, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the second quarter ended June 30, 2026.

Videos

No Data

There is no data to display

Press releases

12.08.2026

Xilio Therapeutics, Inc. (XLO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Videos

No Data

Press releases

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Videos

No Data

Press releases

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Search stocks

Xilio Therapeutics, Inc. (XLO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Videos

No Data

Press releases

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Videos

No Data

Press releases

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates